Antidepressant Trial With P2X7 Antagonist JNJ-54175446

NCT04116606 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

142

Enrollment

OTHER

Sponsor class

Conditions

Depressive Disorder, Major
Inflammation

Interventions

DRUG: Active JNJ-54175446
DRUG: Placebo

Sponsor

CCTU-Core

Collaborators

[object Object]